RepliCel Life Sciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 9,344,584 | 14.4% |
General Public | 23,063,905 | 35.5% |
Individual Insiders | 32,593,071 | 50.1% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
17,401,616 | €3.3k | 0% | no data | |||
10,034,537 | €1.9k | 0% | no data | |||
5,357,900 | €1.0k | 0% | no data | |||
3,986,684 | €765.7 | 0% | no data | |||
1,329,245 | €255.3 | 0% | no data | |||
1,193,426 | €229.2 | 0% | no data | |||
875,632 | €168.2 | 0% | no data | |||
626,920 | €120.4 | 0% | no data | |||
489,572 | €94.0 | 0% | no data | |||
320,500 | €61.6 | 0% | no data | |||
314,815 | €60.5 | 0% | no data | |||
6,808 | €1.3 | 0% | no data |